首页> 外文期刊>Journal of Crohn’s & colitis >Reply to Dr. Chouchana's letter
【24h】

Reply to Dr. Chouchana's letter

机译:回复Chouchana博士的信

获取原文
获取原文并翻译 | 示例
           

摘要

Dear Sir,We would like to thank Dr. Chouchana for the comments on our manuscript and thereby giving us the opportunity to discuss this important topic again.The thiopurine metabolism is complex and several enzymes, besides TPMT, are probably of clinical importance. Clinicians thus need to be aware of the limitations of a TPMT test and use it in a correct clinical context.Our aim was to investigate whether TPMT genotype or phenotype was the best pre-treatment evaluation of TPMT status, since neither method is perfect. It needs to be stressed that these tests, even if used in combination, cannot replace the need for continued monitoring of full blood counts during treatment with thiopurines. Furthermore, the majority of hematological adverse events cannot be explained by the TPMT status.
机译:亲爱的主席先生,我们要感谢Chouchana博士对稿件的评论,从而使我们有机会再次讨论这个重要的话题。硫嘌呤的代谢非常复杂,除TPMT以外,其他几种酶也可能具有临床意义。因此,临床医生需要意识到TPMT测试的局限性,并在正确的临床环境中使用它。我们的目的是调查TPMT基因型或表型是否是TPMT状态的最佳治疗前评估,因为这两种方法都不完美。需要强调的是,即使结合使用这些测试,也不能代替在用硫嘌呤治疗期间继续监测全血细胞计数的需要。此外,大多数血液学不良事件不能通过TPMT状态来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号